Solu is working with Stanford University to solve the growing problem of antibiotic resistance.A startup working with Stanford University to combat the issue of antibiotic resistance has secured $1 million in fresh funds.
Antibiotic resistance is when bacteria start to resist the effect of medication, evolving into 'superbugs'. It renders certain medication ineffective and can cause knock-on effects such as longer hospital visits to extended side effects for patients. Thehas tipped antibiotic resistance to be one of the biggest threats to health and food security.
Beyond its university partnerships, Solu is also targeting research groups to help them inspect new pathogen threats, and examine how resistant these are.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: